MIRA / MIRA Pharmaceuticals, Inc. - Net Long/Short Value

MIRA Pharmaceuticals, Inc.
US ˙ NasdaqCM ˙ US60458C1045

MIRA / MIRA Pharmaceuticals, Inc. - Net Long/Short Value
Den här sidan ger nettovärderingarna långa/korta för varje institutionellt innehav som rapporterats via 13F- eller NPORT-anmälningar. För att beräkna nettolångt/kortt värde adderar vi aktievärdet till köpoptionsvärdet och subtraherar säljoptionsvärdet. Fonder som rapporterar kortlånade positioner kommer att rapportera aktievärden som negativa. Långa nettopositioner kommer att ha positiva siffror i kolumnen netto lång/kort, och korta nettopositioner kommer att ha negativa värden i den kolumnen.
Ägare Eget kapitalvärde
($1000)
Call värde
($1000)
Put värde
($1000)
Net Long/Short
($1000)
Tower Research Capital LLC (TRC)
International Assets Investment Management, Llc
Suncoast Equity Management
State Street Corp
Susquehanna International Group, Llp
Steward Partners Investment Advisory, Llc
Federation des caisses Desjardins du Quebec
Citigroup Inc
Vanguard Global Advisers, LLC
Wells Fargo & Company/mn
Cary Street Partners Financial Llc
Advisor Group Holdings, Inc.
Fifth Third Bancorp
BlackRock, Inc.
Mariner, LLC
Vanguard Capital Management Llc
First American Bank
XTX Topco Ltd
Northern Trust Corp
Caitong International Asset Management Co., Ltd
Vanguard Fiduciary Trust Co
Vanguard Group Inc
Frec Markets, Inc.
Cross Staff Investments Inc
UBS Group AG
Geode Capital Management, Llc
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
DE:K6S 0,87 €
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista